- Coordinator
- Universita Degli Studi Di Napoli Federico Ii, Italy
- Runs
- 1 September 2024 to 31 August 2026
- Status
- Ended early
- EU funding
- €173k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101107015
What the project is doing
In the project's own words, from its summary on CORDIS.
This project will develop the At-home, Maximised Potential DNA/RNA Detecting Device (AMP’D). AMP'D is a hand-held, equipment free point-of-care device that can detect DNA/RNA biomarkers in easily accessible bodily fluids - such as blood, nasal and saliva samples. It is intended for diagnosing both infectious diseases and cancer. Additionally, it can do it at-home and early in disease progression. Both infectious diseases and cancer are leading causes of death globally.
In 2020, cancer accounted for 10 million deaths. Furthermore, Covid-19 alone has accounted for 6.5 million deaths since the start of the pandemic. AMP'D intends to significantly reduce the number of deaths for both diseases - by providing a platform that can allow for ultra-sensitive, low cost and convenient detection. First, AMP'D can detect extremely low concentrations of biomarkers - at the early stages of these diseases.
Second, AMP'D can cut the cost of each test from US$200 (commonly observed with pathological lab tests) to US$10. Finally, AMP'D can enable at-home diagnosis with blood, nasal and saliva samples - thus preventing invasive/uncomfortable procedures that deter many people from getting tested until it is too late. The development of such a device can enable end-users anywhere in the world to detect these diseases - even before symptoms appear.
This can allow for early intervention before prognosis worsens - thus saving lives.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universita Degli Studi Di Napoli Federico Ii | Napoli | Italy | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI